Cancer company Cue Biopharma updates IPO plans

Cancer company Cue Biopharma Inc. (Cambridge, Mass.) amended its proposed IPO on Dec. 5 and now plans to raise up to $60 million through the sale of up to 8 million shares at $7.50. A sale of the max...